3-Chloro-2-(3-cyclobutoxy-4-difluoromethoxyphenyl)-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one → 3-Chloro-2-(3-cyclobutoxy-4-methoxyphenyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one
Reaction equation
[Cl:1][C:2]1[C:10]2[C:9](=[O:11])[NH:8][N:7]=[CH:6][C:5]=2[N:4](COCC[Si](C)(C)C)[C:3]=1[C:20]1[CH:25]=[CH:24][C:23]([O:26][CH3:27])=[C:22]([O:28][CH:29]2[CH2:32][CH2:31][CH2:30]2)[CH:21]=1.ClC1C2C(=O)NN=CC=2N(COCC[Si](C)(C)C)C=1C1C=CC(OC(F)F)=C(OC2CCC2)C=1>>[Cl:1][C:2]1[C:10]2[C:9](=[O:11])[NH:8][N:7]=[CH:6][C:5]=2[NH:4][C:3]=1[C:20]1[CH:25]=[CH:24][C:23]([O:26][CH3:27])=[C:22]([O:28][CH:29]2[CH2:30][CH2:31][CH2:32]2)[CH:21]=1Participants
3
Reactant 2
Product 1
Procedure
Reaction and post treatment were carried out in the same manner as in Example 32-(b) except for using 335 mg (0.70 mmol) of 3-chloro-2-(3-cyclobutoxy-4-methoxyphenyl)-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]-pyridazin-4-one obtained in Example 45-(a) in place of 3-chloro-2-(3-cyclobutoxy-4-difluoromethoxyphenyl)-1-(2-trimethylsilylethoxymethyl)-1,5-dihydropyrrolo[2,3-d]pyridazin-4-one, whereby 204 mg of the title compound was obtained as a white solid. (Yield: 84%)
Workup
- customReaction and post treatment
Sources & evidence
- ORD record
- ord-80cee1a9e0ec482b875ec4082b3749dd
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450319B2
Reaction notes
Loading…